Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
Plasma total homocysteine (Hcy) has been associated with cardiovascular risk in multiple large-scale epidemiological studies, and it has been considered as an independent risk factor for atherosclerosis. Homocysteine lowering, achieved after the introduction of the folate food fortification programm...
Main Authors: | Antoniades, C, Antonopoulos, A, Tousoulis, D, Marinou, K, Stefanadis, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Homocysteine: a risk factor for coronary artery disease?
by: Marinou, K, et al.
Published: (2005) -
Homocysteine lowering: any use in atherosclerosis?
by: Antoniades, C, et al.
Published: (2007) -
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
by: Tousoulis, D, et al.
Published: (2007) -
LOCAL ADIPONECTIN SYNTHESIS IN ADIPOSE TISSUE REGULATES VASCULAR SUPEROXIDE GENERATION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS: INSIGHTS BY USING FUNCTIONAL GENETIC POLYMORPHISMS OF ADIPONECTIN GENE
by: Antoniades, C, et al.
Published: (2011) -
Effects of endothelial nitric oxide synthase gene polymorphisms on oxidative stress, inflammatory status, and coronary atherosclerosis: an example of a transient phenotype.
by: Antoniades, C, et al.
Published: (2007)